Merck hopes to extend gardasil vaccine to men.
Chitale
Radha
R
D000293:Adolescent; D000328:Adult; D052685:Alphapapillomavirus / Q000276:immunology; D001005:Anus Neoplasms / Q000517:prevention & control / Q000821:virology; D002648:Child; D017277:Drug Approval; D004345:Drug Industry / Q000639:trends*; D005260:Female; D005834:Genital Neoplasms, Male / Q000517:prevention & control* / Q000821:virology*; D000068857:Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18; D006801:Humans; D008297:Male; D008389:Marketing of Health Services; D054526:Men's Health; D030361:Papillomavirus Infections / Q000150:complications / Q000517:prevention & control*; D053918:Papillomavirus Vaccines / Q000627:therapeutic use*; D010412:Penile Neoplasms / Q000517:prevention & control / Q000821:virology; D012737:Sex Factors; D012725:Sexual Behavior; D015229:Sexually Transmitted Diseases, Viral / Q000150:complications / Q000517:prevention & control*; D014412:Tumor Virus Infections / Q000150:complications / Q000517:prevention & control*; D014481:United States; D014486:United States Food and Drug Administration; D055815:Young Adult
D000068857:Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18; D053918:Papillomavirus Vaccines